RECURRENT ADULT PRIMARY LIVER CANCER
Clinical trials for RECURRENT ADULT PRIMARY LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT PRIMARY LIVER CANCER trials appear
Sign up with your email to follow new studies for RECURRENT ADULT PRIMARY LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation plus drug may boost survival in advanced liver cancer
Disease control CompletedThis phase 3 trial tested whether adding focused radiation (SBRT) to the drug sorafenib helps people with advanced liver cancer live longer compared to sorafenib alone. The study enrolled 193 adults with liver cancer that could not be surgically removed. Researchers measured over…
Matched conditions: RECURRENT ADULT PRIMARY LIVER CANCER
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
PET-CT scans could sharpen radiation targeting for liver tumors
Knowledge-focused CompletedThis study investigates whether PET-CT scans can accurately measure the radiation dose delivered by radioactive spheres during a liver cancer treatment called radioembolization. Researchers will compare scans taken before and after the procedure in patients with liver tumors. The…
Matched conditions: RECURRENT ADULT PRIMARY LIVER CANCER
Phase: NA • Sponsor: Fox Chase Cancer Center • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC